As on Thursday, Alkermes plc (NASDAQ: ALKS) started slowly as it slid -3.59% to $26.85, before settling in for the price of $27.85 at the close. Taking a more long-term approach, ALKS posted a 52-week range of $20.46-$32.88.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 10.61%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 78.93%. This publicly-traded company’s shares outstanding now amounts to $166.98 million, simultaneously with a float of $161.57 million. The organization now has a market capitalization sitting at $4.42 billion. At the time of writing, stock’s 50-day Moving Average stood at $27.82, while the 200-day Moving Average is $26.58.
Alkermes plc (ALKS) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Drug Manufacturers – Specialty & Generic industry. Alkermes plc’s current insider ownership accounts for 1.88%, in contrast to 109.35% institutional ownership. According to the most recent insider trade that took place on Mar 18 ’24, this organization’s SVP, Chief Commercial Officer sold 10,417 shares at the rate of 28.10, making the entire transaction reach 292,740 in total value, affecting insider ownership by 65,911. Preceding that transaction, on Feb 27 ’24, Company’s VP, Finance (Interim PAO) sold 2,559 for 29.65, making the whole transaction’s value amount to 75,874. This particular insider is now the holder of 7,717 in total.
Alkermes plc (ALKS) Earnings and Revenue Records
Alkermes plc’s EPS increase for this current 12-month fiscal period is 78.93% and is forecasted to reach 2.16 in the upcoming year.
Alkermes plc (NASDAQ: ALKS) Trading Performance Indicators
Let’s observe the current performance indicators for Alkermes plc (ALKS). It’s Quick Ratio in the last reported quarter now stands at 2.61. The Stock has managed to achieve an average true range (ATR) of 0.96. Alongside those numbers, its PE Ratio stands at $15.91, and its Beta score is 0.46. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 2.93. Similarly, its price to free cash flow for trailing twelve months is now 13.51.
In the same vein, ALKS’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 1.69, a figure that is expected to reach 0.77 in the next quarter, and analysts are predicting that it will be 2.16 at the market close of one year from today.
Technical Analysis of Alkermes plc (ALKS)
Through scrutinizing the latest numbers posted by the [Alkermes plc, ALKS], it can be observed that its last 5-days Average volume of 2.45 million was better the volume of 1.84 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 36.83% While, its Average True Range was 1.00.
Raw Stochastic average of Alkermes plc (ALKS) in the period of the previous 100 days is set at 60.21%, which indicates a major rise in contrast to 24.35% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 41.46% that was higher than 33.27% volatility it exhibited in the past 100-days period.
